146 related articles for article (PubMed ID: 12214070)
41. Nurr1 in Parkinson's disease and related disorders.
Chu Y; Le W; Kompoliti K; Jankovic J; Mufson EJ; Kordower JH
J Comp Neurol; 2006 Jan; 494(3):495-514. PubMed ID: 16320253
[TBL] [Abstract][Full Text] [Related]
42. Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
Kalaria RN; Galloway PG; Perry G
Neuropathol Appl Neurobiol; 1991 Jun; 17(3):189-201. PubMed ID: 1891063
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
44. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
Siedlak SL; Jiang Y; Huntley ML; Wang L; Gao J; Xie F; Liu J; Su B; Perry G; Wang X
J Alzheimers Dis; 2017; 58(4):1027-1033. PubMed ID: 28527219
[TBL] [Abstract][Full Text] [Related]
45. Apoptosis in Alzheimer's disease--an update.
Shimohama S
Apoptosis; 2000 Feb; 5(1):9-16. PubMed ID: 11227497
[TBL] [Abstract][Full Text] [Related]
46. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.
Schwab C; DeMaggio AJ; Ghoshal N; Binder LI; Kuret J; McGeer PL
Neurobiol Aging; 2000; 21(4):503-10. PubMed ID: 10924763
[TBL] [Abstract][Full Text] [Related]
47. Activated caspase-9 immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy.
Kawamoto Y; Ayaki T; Urushitani M; Ito H; Takahashi R
Neurosci Lett; 2016 Aug; 628():207-12. PubMed ID: 27345387
[TBL] [Abstract][Full Text] [Related]
48. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Botez G; Probst A; Ipsen S; Tolnay M
Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
[TBL] [Abstract][Full Text] [Related]
49. [Pathologic diagnosis of non-Alzheimer type dementia].
Zhu MW; Wang LN; Li XH; Hu YZ
Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):408-12. PubMed ID: 15498207
[TBL] [Abstract][Full Text] [Related]
50. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
51. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
52. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
Halliday GM; Macdonald V; Henderson JM
Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
[TBL] [Abstract][Full Text] [Related]
54. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis.
Stadelmann C; Brück W; Bancher C; Jellinger K; Lassmann H
J Neuropathol Exp Neurol; 1998 May; 57(5):456-64. PubMed ID: 9596416
[TBL] [Abstract][Full Text] [Related]
55. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
Fossati S; Giannoni P; Solesio ME; Cocklin SL; Cabrera E; Ghiso J; Rostagno A
Neurobiol Dis; 2016 Feb; 86():29-40. PubMed ID: 26581638
[TBL] [Abstract][Full Text] [Related]
56. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
[TBL] [Abstract][Full Text] [Related]
57. C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Masliah E
Acta Neuropathol; 2000 Mar; 99(3):296-304. PubMed ID: 10663973
[TBL] [Abstract][Full Text] [Related]
58. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
59. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
60. Autophagy and apoptosis dysfunction in neurodegenerative disorders.
Ghavami S; Shojaei S; Yeganeh B; Ande SR; Jangamreddy JR; Mehrpour M; Christoffersson J; Chaabane W; Moghadam AR; Kashani HH; Hashemi M; Owji AA; Łos MJ
Prog Neurobiol; 2014 Jan; 112():24-49. PubMed ID: 24211851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
